Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Market sentiment signals for Ligand Pharmaceuticals (LGND): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Buy
11 analysts
Options Flow (P/C)
—
Avg Consensus PT
$297
+4.4%
Highest Price Target
$388
+36.5%
Lowest Price Target
$140
-50.7%
Short Interest
14.9%
Rising — Bearish
Insider Activity (30d)
Net Seller
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Aug 14, 2026 | Leerink Partners | David Risinger— | +16.1% | $330 | Initiate | Outperform |
| Aug 7, 2026 | RBC Capital | Douglas Miehm— | +21.4% | $340 → $345 | Maintained | Outperform |